← Evidence map

ArticleNeoplasia (New York, N.Y.)2009

LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.

Kohei Nakata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 19568416